SLC2A5 and acute myeloid leukemia: A study on acute myeloid leukemia (AML) showed that SLC2A5 upregulation occurs in AML, and blocking the pharmacological process of SLC2A5 regulating fructose uptake could improve the phenotype of leukemia [10].